Default company panoramic image
Logo

Koli Inc

Percutaneous solution for gallstone disease

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Fremont, CA, USA
  • Currency USD
  • Founded December 2011
  • Employees 2

Company Summary

Kōli is a medical device company developing a percutaneous solution for gallstone disease. The new device and procedure will provide a non-surgical alternative for those unable to tolerate surgery, and eliminate complications for those who are waiting for surgery. The solution will make it easier for physicians to treat their patients and reduce total healthcare costs.

Team

  • Default avatar
    Christopher Cheng
    CEO

    Chris co-founded Kōli with Dr. Callaghan after serving as an entrepreneur in residence at Nitinol Devices & Components. Dr. Cheng has 15+ years experience in biomedical research and medical devices and has worked on several catheter-delivery Nitinol implants at large and small companies. He serves as Kōli’s Chief Executive Officer.

  • Default avatar
    Matthew Callaghan
    CMO

    Matt was a Fellow in Biodesign at Stanford University and a general surgery resident. Dr. Callaghan is the lead inventor of this technology and the founder of Kōli. He also founded OneBreath, Inc., the manufacturer of novel, low-cost ventilator which is now heading towards commercialization. He will serve as Kōli’s Chief Medical Officer.

Previous Investors

  • Default avatar
    NIH/Spectrum
    Unconfirmed
    Default avatar
    National Collegiate Inventors and Innovators Alliance
    Unconfirmed
    Default avatar
    Nitinol Devices & Components
    Unconfirmed